Global Digital Womens healthcare And Diagnostics Market Research Report Segmented by Type (Mobile Apps, Wearable Devices, Diagnostic Tools, Others); By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic Care, General Healthcare & Wellness); and Region - Size, Share, Growth Analysis | Forecast (2024 2030)

Market Size and Overview:

As per our research report, the global Digital Women’s healthcare and Diagnostics Market size was USD 3.1 billion in 2023 and is estimated to grow to USD 10.39 billion by 2030. This market is witnessing a healthy CAGR of 18.85% from 2024 - 2030.

Industry Overview:

In 2021, a digital health startup concentrating on women's healthcare has secured $1.3 billion through 26 transactions, nearly doubling the funding of the previous year with four months still remaining. The surge in funding for women's health extends beyond traditional areas such as pregnancy and fertility support, now encompassing primary care, chronic illness management, and menopause.

According to reports from the company, funding for the women's health sector represented 7% of total digital health funding through August 2021, marking the second-highest share since Rock Health began tracking in 2011. Companies are increasingly offering comprehensive health solutions for women, integrating general health, sexual well-being, and family planning. This includes a diverse portfolio covering women's health, sexual well-being, fertility, vitamin deficiency, and daily health support under brands like Rory (Ro brand) for skincare and sexual well-being.

As investment in the market rises, there's evidence of maturity among digital women's health startups. In 2017, the median age of women-led companies was 4, with none reaching Series C or above. In 2021, the median age has risen to 6, and 31% of women's digital health transactions from January to August 2021 were at Series C and above, as reported by Rock Health. Nurx CEO Varsha Rao notes that with an expanding array of digital health solutions, patients are consolidating their care within a single company. She mentioned that 10% of Nurx patients utilize the platform for multiple treatment types.

COVID-19 Impact on Women Digital Healthcare Industry:

The COVID-19 pandemic has had a profound impact on numerous industries, both large and small. Recognized as one of the most dangerous pandemics affecting a global population, COVID-19 spread rapidly from Wuhan, China, prompting governments worldwide to implement strict lockdown measures. These measures disrupted global supply chains, affecting manufacturing, product sales, and delivery schedules on a global scale.

Furthermore, various countries declared assisted reproductive technology non-essential during the pandemic. Consequently, digital fitness solutions, such as smartphone apps and wearable tracking devices, experienced significant growth in 2020. However, the production of devices related to women's digital health faced severe constraints due to industry closures.

Market Drivers:

The market's growth is propelled by a rising number of investment initiatives by established market players:

A prominent trend in the women's healthcare device market is the launch of numerous investment initiatives, expected to substantially contribute to market growth. The rapid pace of these investments offers several advantages, including increased availability of simpler and more cost-effective solutions, leading to broader adoption of these medical devices.

The substantial prevalence of women-centric diseases also fuels market growth:

Frequent outbreaks of diseases specifically affecting women, such as anemia, osteoporosis, breast cancer, and menopause, pose common health challenges globally. In addition to their prevalence, these diseases can be perilous for patients. Given the increasing frequency of such diseases, there's a growing need for effective supplies to address them, leading to a continuous demand for drugs to treat these conditions.

Market Restraints:

The growth of the women's healthcare market is hindered by negative side effects associated with certain products:

Despite women having higher rates of life-threatening diseases than men, several factors impede the expansion of the women's health sector. Notably, certain drugs negatively impact women's health, with examples such as birth control pills causing side effects like bleeding between periods, breast tenderness, nausea, headaches, and other discomforts. These side effects can be particularly painful and uncomfortable for women.

Global Digital Women’s healthcare And Diagnostics Market Segmentation:

Digital Women’s Healthcare and Diagnostics Market - By Type

• Mobile Apps
• Wearable Devices
• Diagnostic Tools
• Others

Categorized by type, the market was predominantly led by the mobile app segment, capturing the largest revenue share of 65.9% in 2021. This dominance is attributed to the escalating adoption of mobile apps for managing the menstrual cycle, fertility cycle, and pregnancy. Simultaneously, the wearable device segment is projected to experience the swiftest growth in the forecast period, while diagnostic tools are progressively gaining attention with continuous innovations from various companies.

The swift adoption of these digital tools is propelled by their user-friendly nature and easy accessibility. Ongoing technological advancements in the realm of digital health empower women to remain well-informed about their health, enabling them to make informed decisions grounded in practical insights.

Digital Women’s Healthcare and Diagnostics Market - By Application

• Reproductive Health
• Pregnancy & Nursing Care
• Pelvic Care
• General Healthcare & Wellness

In terms of application, the reproductive health segment dominated the market in 2021, securing the largest revenue share of 41.0%. This dominance is particularly evident in the widespread adoption of mobile applications for managing various aspects of women's healthcare. Conversely, the general health and wellness segment is poised to exhibit the fastest growth during the forecast period.

The market is progressively addressing additional women's health concerns, including pelvic floor care, pregnancy management, and the management of chronic illnesses such as breast and cervical cancer. Noteworthy advancements, such as home screening for early cancer detection, platforms for self-monitoring pregnancy indicators, and analytical platforms identifying women at risk of preterm birth and other complications, are contributing to these expansions.

Digital Women’s Healthcare and Diagnostics Market - By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East
• Africa

From a geographical perspective, North America took the lead in the market, commanding the largest revenue share at 41.1%. This is attributed to the presence of advanced technological infrastructure, superior access to cutting-edge equipment, enhanced diagnostic and therapeutic capabilities, and higher disposable income. Conversely, Asia-Pacific is anticipated to exhibit the fastest growth from 2023 to 2030. Emerging economies in this region, such as China, India, and Singapore, are demonstrating robust economic growth.

Government initiatives and a favorable regulatory environment continue to propel the growth of the digital women's health market in these countries. Efforts are also underway to address socio-cultural barriers surrounding women's healthcare and diagnostics in these regions.

Key Players:

• HeraMD
• ISONO Health
• Clue By Biowink
• Charo Technology Ltd.
• Natural Cycles
• Ava Science, Inc.
• Glow
• Lucina Health
• mobileODt Ltd
• Brater
• Athena Feminine Technologie
• Plackel Tech

Recently, the field of women's digital health has become highly competitive, encompassing various products, services, devices, diagnostics, and software tailored to address women's specific needs, including reproductive health, fertility, and sexuality. Numerous service providers are actively exploring the integration of artificial intelligence, machine learning, and the Internet of Things to develop advanced digital health applications catering to women.

Diligently, these companies are striving to deliver technologically sophisticated apps and devices that effectively address women's health concerns in a personalized manner. With approximately 200 companies operating in this sector, the market is gradually expanding. Given that the target consumer base constitutes around 50% of the global population, there exists ample opportunity for new entrants and the expansion of existing businesses to meet the demands of the market.

One noteworthy development is the approval granted by the US FDA to the NC Birth Control application in 2018, developed by Natural Cycles. This application serves as a contraceptive method and aids in the regular tracking of the menstrual cycle.

Industry players are investing significantly in research and development to create technologically advanced systems, gaining a competitive edge over others and contributing to the industry's economic growth. Anticipated in the coming years are several mergers and acquisitions as companies take proactive measures to secure market share and offer a diverse product portfolio.

Recent Notable Events in the Digital Women’s Healthcare and Diagnostics Market:

Product Launch - In April 2021, Hims & Hers, a telehealth company specializing in online sales of prescription and over-the-counter drugs, as well as personal care products, expanded its offerings with the introduction of hers, a women’s health business focusing on birth control, sexual health, and skincare and haircare products.

Announcement - In 2022, Elvie announced the availability of an NHS supply chain utilizing Bluetooth for providing biofeedback therapy to women globally. This development was highlighted in 2017 at the International Continence Society Conference.